Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: How much alcohol should be injected?

Catheterization and Cardiovascular Interventions

Volumn 65, Issue 2, 2005, Pages 313-314

  Cheng, Tsung O ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ARTIFICIAL HEART PACEMAKER; CATHETER ABLATION; COMPLETE HEART BLOCK; HEART INFARCTION; HEART INFARCTION SIZE; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; LETTER;

CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; ETHANOL; HEART BLOCK; HUMANS; PACEMAKER, ARTIFICIAL; SOLVENTS;

EID: 20344365828     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.20384     Document Type: Letter

References (11)

1. Veselka J, Procházková Š, Duchoňová R, Bolomová-Homolová I, Páleníčková J, Tesař D, Červinka P, Honěk T. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: lower alcohol dose reduces size of infarction and has comparable hemodynamic and clinical outcome. Catheter Cardiovasc Interv 2004;63:231-235.
2. Kimmelstiel CD, Maron BJ. Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy. Circulation 2004; 109:452-455.
3. Li ZQ, Cheng TO, Zhang WW, Qiao SB, Zhao LY, Jin YZ, Guan RM, Liu L. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: the Chinese experience in 119 patients from a single center. Int J Cardiol 2004;93:191-196.
4. Li ZQ, Cheng TO, Liu L, Jin YZ, Zhang M, Guan RM, Yuan L, Hu J, Zhang WW. Experimental study of relationship between intracoronary alcohol injection and the size of resultant myocardial infarct. Int J Cardiol 2003;91:93-96.
5. Cheng TO. In percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy, it is not the speed of intracoronary alcohol injection but the amount of alcohol injected that determines the resultant infarct size. Circulation 2004;110:e23.
6. Seggewiss H. Current status of alcohol septal ablation for patients with hypertrophic cardiomyopathy. Curr Cardiol Rep 2001;3:160-166.
7. Faber L, Seggewiss H, Gleichman U. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography. Circulation 1998;98:2415-2421.
8. Lakkis NM, Nagueh SF, Kleiman NS, et al. Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation 1998;98:1750-1755.
9. Reinhard W, Ten Gate FJ, Scholten M, de Laat LE, Vos J. Permanent pacing for complete atrioventricular block after nonsurgical (alcohol) septal reduction in patients with obstructive hypertrophic cardiomyopathy. Am J Cardiol 2004;93:1064-1066.
10. Cheng TO. Conservative management of complete heart block complicating percutaneous transluminal septal myocardial ablation for patients with obstructive hypertrophic cardiomyopathy. Am J Cardiol 2004;94:982.
11. Kern MJ, Holmes DG, Simpson C, Bitar SR, Rajjoub H. Delayed occurrence of complete heart block without warning after alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Catheter Cardiovasc Interv 2002;56:503-507.